Oct 02, 2017 11:00 am UTC| Business
Top-line data expected in Q1 2018 TEL AVIV, Israel, Oct. 02, 2017 -- VBL Therapeutics (NASDAQ:VBLT), today announced that the independent Data Safety Monitoring Committee (DSMC) met on September 28, 2017 to conduct...
Oct 02, 2017 11:00 am UTC| Business
Reno, Oct. 02, 2017 -- Enhance Skin Products Inc. (OTCBB: EHSK), today announced that it has placed its Consolidated Financial Statements for the period to April 30, 2017 (Unaudited) on its website...
Brookfield Renewable Announces Quarterly Dividend Rate on Its Series 2 Preference Shares
Oct 02, 2017 11:00 am UTC| Business
All amounts in Canadian dollars unless otherwise stated BROOKFIELD, News, Oct. 02, 2017 -- Brookfield Renewable Partners L.P. (TSX:BEP.UN) (NYSE:BEP) (“Brookfield Renewable”) today announced the quarterly dividend on...
Assembly Biosciences Announces 2017 AASLD Presentations
Oct 02, 2017 11:00 am UTC| Business
INDIANAPOLIS, Oct. 02, 2017 -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel...
Oct 02, 2017 11:00 am UTC| Business
BEVERLY, Mass., Oct. 02, 2017 -- Innovation Pharmaceuticals Inc. (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, today announces that the last patient has completed study treatment in the...
Asterias Announces Two Significant Developments for Spinal Cord Injury Program
Oct 02, 2017 11:00 am UTC| Business
67% of Cohort 2 subjects have recovered two or more motor levels on at least one side through 12 months ...
Oct 02, 2017 11:00 am UTC| Business
VICTORIA, British Columbia, Oct. 02, 2017 -- Emerald Health Therapeutics Inc. (“EHT”) (TSXV:EMH) (OTCQX:EMHTF) is pleased to announce the appointment of Chris Wagner as Chief Executive Officer and a director of EHT. Mr....